Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Oncology
|
gptkbp:affects |
gptkb:B_lymphocytes
|
gptkbp:age_group |
gptkb:children
young adults |
gptkbp:associated_with |
gptkb:Philadelphia_chromosome
central nervous system involvement hyperleukocytosis |
gptkbp:clinical_trial |
gptkb:immunotherapy
targeted therapies new therapies |
gptkbp:common_treatment_regimen |
maintenance therapy
consolidation therapy induction therapy |
gptkbp:complication |
gptkb:disease
organ damage bleeding disorders |
gptkbp:death |
lower in adults
higher in children |
gptkbp:diagnosis |
gptkb:CD22
gptkb:CD19 blood tests varies by age bone marrow biopsy Td T varies by genetic factors |
gptkbp:events |
psychosocial support
regular blood tests monitoring for relapse |
https://www.w3.org/2000/01/rdf-schema#label |
B-cell ALL
|
gptkbp:is_common_in |
males
Caucasian populations African American populations Hispanic populations |
gptkbp:is_involved_in |
gptkb:Leukemia_&_Lymphoma_Society
gptkb:Cancer_Support_Community local cancer support groups |
gptkbp:research_focus |
genetic mutations
long-term effects of treatment treatment resistance |
gptkbp:risk_factor |
genetic disorders
exposure to radiation previous chemotherapy |
gptkbp:symptoms |
fatigue
weight loss fever pale skin easy bruising |
gptkbp:treatment |
gptkb:Medicine
radiation therapy chemotherapy remission stem cell transplant |
gptkbp:type_of |
gptkb:Burkitt_leukemia
gptkb:Ph-positive_ALL gptkb:Precursor_B-cell_ALL |
gptkbp:bfsParent |
gptkb:Oncology
|
gptkbp:bfsLayer |
4
|